Medicaid Coverage For Residential Substance Use Disorder Treatment: Addressing The Institution For Mental Disease Exclusion Policy

This article was informed and adapted from a proprietary report created for the Medicaid Evidence-based Decisions Project (MED), a self-governing collaborative of 19 state Medicaid agencies, supported by the Center for Evidence-based Policy (the Center) at Oregon Health and Science University. The Center produces evidence and policy reports requested by the MED collaborative to help state policy makers make evidence-based decisions for improving health outcomes. For more information about MED or the Center, please call [phone] or visit centerforevidencebasedpolicy.org.
This report was approved for publication by the MED collaborative executive team. Research reported in this publication was supported by the National Institutes of Health’s (NIH’s) National Institute on Drug Abuse under award No. F30DA044700. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Source: Health Affairs Blog - August 31, 2017 Category: Health Management Authors: Kelsey C. Priest, Allison W. Leof, Dennis McCarty and Valerie King Tags: Insurance and Coverage Medicaid and CHIP Population Health Institution for Mental Disease exclusion policy opioid crisis Section 1115 waiver substance use disorder substance use disorder treatment Source Type: blogs